Search
Skip to Search Results
Filter
Subject / Keyword
Author / Creator / Contributor
Year
Collections
Languages
Item type
Departments
-
The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers
DownloadSpring 2013
How the costs of research and its associated risks contribute to a minimum price that would support continued private pharmaceutical investment is unclear. We employed a linear cost-volume-revenue breakeven analysis to equate initial capital investment and risk, and its associated...
1 - 1 of 1